United States Injectable Anticoagulants Market by Manufacturers, States, Type and Application, Forecast to 2022

June 2017 | 122 pages | ID: U20A5600673EN
GlobalInfoResearch

Abstracts

'The injectable anticoagulants include low molecular weight heparin (LMWH) agents (dalteparin [Fragmin?], enoxaparin [Lovenox?]) and factor Xa inhibitors (fondaparinux [Arixtra?]).

In general, the injectable anticoagulants are Food and Drug Administration (FDA)-approved for prophylaxis and/or treatment of venous thromboembolism.'

Scope of the Report:

This report focuses on the Injectable Anticoagulants in United States market, to split the market based on manufacturers, states, type and application.

Market Segment by Manufacturers, this report covers

• Sanofi
• Genentech (Roche)
• Boehringer Ingelheim
• Pfizer
• The Medicines Company
• Aspen
• Otsuka

Market Segment by States, covering

• California
• Texas
• New York
• Florida
• Illinois

Market Segment by Type, covers

• Low-molecular-weight Heparin (LMWH)
• Direct Thrombin Inhibitor (DTI)
• Other

Market Segment by Applications, can be divided into

• VTE
• ACS/MI
• AF
• Other

There are 17 Chapters to deeply display the United States Injectable Anticoagulants market.

Chapter 1, to describe Injectable Anticoagulants Introduction, product type and application, market overview, market analysis by States, market opportunities, market risk, market driving force;

Chapter 2, to analyze the manufacturers of Injectable Anticoagulants, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the United States market by States, covering California, New York, Texas, Illinois and Florida, with sales, price, revenue and market share of Injectable Anticoagulants, for each state, from 2012 to 2017;

Chapter 5 and 6, to show the market by type and application, with sales, price, revenue, market share and growth rate by type, application, from 2012 to 2017;

Chapter 7, 8, 9, 10 and 11, to analyze the key States by Type and Application, covering California, New York, Texas, Illinois and Florida, with sales, revenue and market share by types and applications;

Chapter 12, Injectable Anticoagulants market forecast, by States, type and application, with sales, price, revenue and growth rate forecast, from 2017 to 2022;

Chapter 13, to analyze the manufacturing cost, key raw materials and manufacturing process etc.

Chapter 14, to analyze the industrial chain, sourcing strategy and downstream end users (buyers);

Chapter 15, to describe sales channel, distributors, traders, dealers etc.

Chapter 16 and 17, to describe Injectable Anticoagulants Research Findings and Conclusion, Appendix, methodology and data source.

Contents

1 MARKET OVERVIEW

1.1 Injectable Anticoagulants Introduction
1.2 Market Analysis by Type
  1.2.1 Low-molecular-weight Heparin (LMWH)
  1.2.2 Direct Thrombin Inhibitor (DTI)
  1.2.3 Other
1.3 Market Analysis by Applications
  1.3.1 VTE
  1.3.2 ACS/MI
  1.3.3 AF
  1.3.4 Other
1.4 Market Analysis by States
  1.4.1 California Status and Prospect (2012-2022)
  1.4.2 Texas Status and Prospect (2012-2022)
  1.4.3 New York Status and Prospect (2012-2022)
  1.4.4 Florida Status and Prospect (2012-2022)
  1.4.5 Illinois Status and Prospect (2012-2022)
1.5 Market Dynamics
  1.5.1 Market Opportunities
  1.5.2 Market Risk
  1.5.3 Market Driving Force

2 MANUFACTURERS PROFILES

2.1 Sanofi
  2.1.1 Profile
  2.1.2 Injectable Anticoagulants Type and Applications
    2.1.2.1 Type
    2.1.2.2 Type
  2.1.3 Sanofi Injectable Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.1.4 Business Overview
  2.1.5 Sanofi News
2.2 Genentech (Roche)
  2.2.1 Profile
  2.2.2 Injectable Anticoagulants Type and Applications
    2.2.2.1 Type
    2.2.2.2 Type
  2.2.3 Genentech (Roche) Injectable Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.2.4 Business Overview
  2.2.5 Genentech (Roche) News
2.3 Boehringer Ingelheim
  2.3.1 Profile
  2.3.2 Injectable Anticoagulants Type and Applications
    2.3.2.1 Type
    2.3.2.2 Type
  2.3.3 Boehringer Ingelheim Injectable Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.3.4 Business Overview
  2.3.5 Boehringer Ingelheim News
2.4 Pfizer
  2.4.1 Profile
  2.4.2 Injectable Anticoagulants Type and Applications
    2.4.2.1 Type
    2.4.2.2 Type
  2.4.3 Pfizer Injectable Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.4.4 Business Overview
  2.4.5 Pfizer News
2.5 The Medicines Company
  2.5.1 Profile
  2.5.2 Injectable Anticoagulants Type and Applications
    2.5.2.1 Type
    2.5.2.2 Type
  2.5.3 The Medicines Company Injectable Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.5.4 Business Overview
  2.5.5 The Medicines Company News
2.6 Aspen
  2.6.1 Profile
  2.6.2 Injectable Anticoagulants Type and Applications
    2.6.2.1 Type
    2.6.2.2 Type
  2.6.3 Aspen Injectable Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.6.4 Business Overview
  2.6.5 Aspen News
2.7 Otsuka
  2.7.1 Profile
  2.7.2 Injectable Anticoagulants Type and Applications
    2.7.2.1 Type
    2.7.2.2 Type
  2.7.3 Otsuka Injectable Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.7.4 Business Overview
  2.7.5 Otsuka News

3 UNITED STATES INJECTABLE ANTICOAGULANTS MARKET COMPETITION, BY MANUFACTURER

3.1 United States Injectable Anticoagulants Sales and Market Share by Manufacturer (2016-2017)
3.2 United States Injectable Anticoagulants Revenue and Market Share by Manufacturer (2016-2017)
3.3 United States Injectable Anticoagulants Price by Manufacturers (2016-2017)
3.4 Market Concentration Rate
  3.4.1 Top 3 Injectable Anticoagulants Manufacturer Market Share
  3.4.2 Top 5 Injectable Anticoagulants Manufacturer Market Share
3.5 Market Competition Trend

4 UNITED STATES INJECTABLE ANTICOAGULANTS MARKET ANALYSIS BY STATES

4.1 United States Injectable Anticoagulants Sales Market Share by States
4.2 United States Injectable Anticoagulants Sales by States (2012-2017)
4.3 United States Injectable Anticoagulants Revenue (Value) by States (2012-2017)

5 UNITED STATES MARKET SEGMENTATION INJECTABLE ANTICOAGULANTS BY TYPE

5.1 United States Injectable Anticoagulants Sales, Revenue and Market Share by Type (2012-2017)
  5.1.1 United States Injectable Anticoagulants Sales and Market Share by Type (2012-2017)
  5.1.2 United States Injectable Anticoagulants Revenue and Market Share by Type (2012-2017)
5.2 Low-molecular-weight Heparin (LMWH) Sales Growth and Price
  5.2.1 United States Low-molecular-weight Heparin (LMWH) Sales Growth (2012-2017)
  5.2.2 United States Low-molecular-weight Heparin (LMWH) Price (2012-2017)
5.3 Direct Thrombin Inhibitor (DTI) Sales Growth and Price
  5.3.1 United States Direct Thrombin Inhibitor (DTI) Sales Growth (2012-2017)
  5.3.2 United States Direct Thrombin Inhibitor (DTI) Price (2012-2017)
5.4 Other Sales Growth and Price
  5.4.1 United States Other Sales Growth (2012-2017)
  5.4.2 United States Other Price (2012-2017)

6 UNITED STATES MARKET SEGMENTATION INJECTABLE ANTICOAGULANTS BY APPLICATION

6.1 United States Injectable Anticoagulants Sales Market Share by Application (2012-2017)
6.2 VTE Sales Growth (2012-2017)
6.3 ACS/MI Sales Growth (2012-2017)
6.4 AF Sales Growth (2012-2017)
6.5 Other Sales Growth (2012-2017)

7 CALIFORNIA INJECTABLE ANTICOAGULANTS SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS

7.1 California Injectable Anticoagulants Revenue, Sales and Growth Rate (2012-2017)
7.2 California Injectable Anticoagulants Sales and Market Share by Type
7.3 California Injectable Anticoagulants Sales by Application (2012-2017)

8 NEW YORK INJECTABLE ANTICOAGULANTS SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS

8.1 New York Injectable Anticoagulants Revenue, Sales and Growth Rate (2012-2017)
8.2 New York Injectable Anticoagulants Sales and Market Share by Type
8.3 New York Injectable Anticoagulants Sales by Application (2012-2017)

9 TEXAS INJECTABLE ANTICOAGULANTS SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS

9.1 Texas Injectable Anticoagulants Revenue, Sales and Growth Rate (2012-2017)
9.2 Texas Injectable Anticoagulants Sales and Market Share by Type
9.3 Texas Injectable Anticoagulants Sales by Application (2012-2017)

10 FLORIDA INJECTABLE ANTICOAGULANTS SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS

10.1 Florida Injectable Anticoagulants Revenue, Sales and Growth Rate (2012-2017)
10.2 Florida Injectable Anticoagulants Sales and Market Share by Type
10.3 Florida Injectable Anticoagulants Sales by Application (2012-2017)

11 ILLINOIS INJECTABLE ANTICOAGULANTS SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS

11.1 Illinois Injectable Anticoagulants Revenue, Sales and Growth Rate (2012-2017)
11.2 Illinois Injectable Anticoagulants Sales and Market Share by Type
11.3 Illinois Injectable Anticoagulants Sales by Application (2012-2017)

12 INJECTABLE ANTICOAGULANTS MARKET FORECAST (2017-2022)

12.1 United States Injectable Anticoagulants Sales, Revenue and Growth Rate (2017-2022)
12.2 Injectable Anticoagulants Market Forecast by States (2017-2022)
12.3 Injectable Anticoagulants Market Forecast by Type (2017-2022)
12.4 Injectable Anticoagulants Market Forecast by Application (2017-2022)

13 INJECTABLE ANTICOAGULANTS MANUFACTURING COST ANALYSIS

13.1 Injectable Anticoagulants Key Raw Materials Analysis
  13.1.1 Key Raw Materials
  13.1.2 Price Trend of Key Raw Materials
  13.1.3 Key Suppliers of Raw Materials
  13.1.4 Market Concentration Rate of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
  13.2.1 Raw Materials
  13.2.2 Labor Cost
  13.2.3 Manufacturing Expenses
13.3 Manufacturing Process Analysis of Injectable Anticoagulants

14 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

14.1 Injectable Anticoagulants Industrial Chain Analysis
14.2 Upstream Raw Materials Sourcing
14.3 Raw Materials Sources of Injectable Anticoagulants Major Manufacturers in 2016
14.4 Downstream Buyers

15 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS

15.1 Sales Channel
  15.1.1 Direct Marketing
  15.1.2 Indirect Marketing
  15.1.3 Marketing Channel Future Trend
15.2 Distributors, Traders and Dealers

16 RESEARCH FINDINGS AND CONCLUSION

17 APPENDIX

17.1 Methodology
17.2 Analyst Introduction
17.3 Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Figure Injectable Anticoagulants Picture
Table Product Specifications of Injectable Anticoagulants
Figure United States Sales Market Share of Injectable Anticoagulants by Types in 2016
Table Types of Injectable Anticoagulants
Figure Low-molecular-weight Heparin (LMWH) Picture
Table Major Manufacturers of Low-molecular-weight Heparin (LMWH)
Figure Direct Thrombin Inhibitor (DTI) Picture
Table Major Manufacturers of Direct Thrombin Inhibitor (DTI)
Figure Other Picture
Table Major Manufacturers of Other
Table United States Injectable Anticoagulants Sales Market Share by Applications in 2016
Table Applications of Injectable Anticoagulants
Figure VTE Picture
Figure ACS/MI Picture
Figure AF Picture
Figure Other Picture
Figure California Injectable Anticoagulants Revenue (Million USD) and Growth Rate (2012-2022)
Figure Texas Injectable Anticoagulants Revenue (Million USD) and Growth Rate (2012-2022)
Figure New York Injectable Anticoagulants Revenue (Million USD) and Growth Rate (2012-2022)
Figure Florida Injectable Anticoagulants Revenue (Million USD) and Growth Rate (2012-2022)
Figure Illinois Injectable Anticoagulants Revenue (Million USD) and Growth Rate (2012-2022)
Table Sanofi Basic Information, Manufacturing Base and Competitors
Table Sanofi Injectable Anticoagulants Type and Applications
Table Sanofi Injectable Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Genentech (Roche) Basic Information, Manufacturing Base and Competitors
Table Genentech (Roche) Injectable Anticoagulants Type and Applications
Table Genentech (Roche) Injectable Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table Boehringer Ingelheim Injectable Anticoagulants Type and Applications
Table Boehringer Ingelheim Injectable Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Injectable Anticoagulants Type and Applications
Table Pfizer Injectable Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table The Medicines Company Basic Information, Manufacturing Base and Competitors
Table The Medicines Company Injectable Anticoagulants Type and Applications
Table The Medicines Company Injectable Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Aspen Basic Information, Manufacturing Base and Competitors
Table Aspen Injectable Anticoagulants Type and Applications
Table Aspen Injectable Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Otsuka Basic Information, Manufacturing Base and Competitors
Table Otsuka Injectable Anticoagulants Type and Applications
Table Otsuka Injectable Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table United States Injectable Anticoagulants Sales by Manufacturer (2016-2017)
Figure United States Injectable Anticoagulants Sales Market Share by Manufacturer in 2016
Figure United States Injectable Anticoagulants Sales Market Share by Manufacturer in 2017
Table United States Injectable Anticoagulants Revenue by Manufacturer (2016-2017)
Figure United States Injectable Anticoagulants Revenue Market Share by Manufacturer in 2015
Figure United States Injectable Anticoagulants Revenue Market Share by Manufacturer in 2016
Table United States Injectable Anticoagulants Price by Manufacturers (2016-2017)
Figure Top 3 Injectable Anticoagulants Manufacturer Market Share in 2016
Figure Top 3 Injectable Anticoagulants Manufacturer Market Share in 2017
Figure Top 5 Injectable Anticoagulants Manufacturer Market Share in 2016
Figure Top 5 Injectable Anticoagulants Manufacturer Market Share in 2017
Figure United States Injectable Anticoagulants Sales and Growth (2012-2017)
Table United States Injectable Anticoagulants Sales by States (2012-2017)
Table United States Injectable Anticoagulants Sales Market Share by States (2012-2017)
Figure United States 2012 Injectable Anticoagulants Sales Market Share by States
Figure United States 2016 Injectable Anticoagulants Sales Market Share by States
Figure United States Injectable Anticoagulants Revenue and Growth (2012-2017)
Table United States Injectable Anticoagulants Revenue by States (2012-2017)
Table United States Injectable Anticoagulants Revenue Market Share by States (2012-2017)
Table United States 2012 Injectable Anticoagulants Revenue Market Share by States
Table United States 2016 Injectable Anticoagulants Revenue Market Share by States
Table United States Injectable Anticoagulants Sales by Type (2012-2017)
Table United States Injectable Anticoagulants Sales Share by Type (2012-2017)
Table United States Injectable Anticoagulants Revenue by Type (2012-2017)
Table United States Injectable Anticoagulants Revenue Share by Type (2012-2017)
Figure United States Low-molecular-weight Heparin (LMWH) Sales Growth (2012-2017)
Figure United States Low-molecular-weight Heparin (LMWH) Price (2012-2017)
Figure United States Direct Thrombin Inhibitor (DTI) Sales Growth (2012-2017)
Figure United States Direct Thrombin Inhibitor (DTI) Price (2012-2017)
Figure United States Other Sales Growth (2012-2017)
Figure United States Other Price (2012-2017)
Table United States Injectable Anticoagulants Sales by Application (2012-2017)
Table United States Injectable Anticoagulants Sales Share by Application (2012-2017)
Figure United States VTE Sales Growth (2012-2017)
Figure United States ACS/MI Sales Growth (2012-2017)
Figure United States AF Sales Growth (2012-2017)
Figure United States Other Sales Growth (2012-2017)
Figure California Injectable Anticoagulants Revenue and Growth (2012-2017)
Figure California Injectable Anticoagulants Sales and Growth (2012-2017)
Table California Injectable Anticoagulants Sales by Type (2012-2017)
Table California Injectable Anticoagulants Sales Market Share by Type (2012-2017)
Table California Injectable Anticoagulants Sales by Application (2012-2017)
Table California Injectable Anticoagulants Sales Market Share by Application (2012-2017)
Figure New York Injectable Anticoagulants Revenue and Growth (2012-2017)
Figure New York Injectable Anticoagulants Sales and Growth (2012-2017)
Table New York Injectable Anticoagulants Sales by Type (2012-2017)
Table New York Injectable Anticoagulants Sales Market Share by Type (2012-2017)
Table New York Injectable Anticoagulants Sales by Application (2012-2017)
Table New York Injectable Anticoagulants Sales Market Share by Application (2012-2017)
Figure Texas Injectable Anticoagulants Revenue and Growth (2012-2017)
Figure Texas Injectable Anticoagulants Sales and Growth (2012-2017)
Table Texas Injectable Anticoagulants Sales by Type (2012-2017)
Table Texas Injectable Anticoagulants Sales Market Share by Type (2012-2017)
Table Texas Injectable Anticoagulants Sales by Application (2012-2017)
Table Texas Injectable Anticoagulants Sales Market Share by Application (2012-2017)
Figure Florida Injectable Anticoagulants Revenue and Growth (2012-2017)
Figure Florida Injectable Anticoagulants Sales and Growth (2012-2017)
Table Florida Injectable Anticoagulants Sales by Type (2012-2017)
Table Florida Injectable Anticoagulants Sales Market Share by Type (2012-2017)
Table Florida Injectable Anticoagulants Sales by Application (2012-2017)
Table Florida Injectable Anticoagulants Sales Market Share by Application (2012-2017)
Figure Illinois Injectable Anticoagulants Revenue and Growth (2012-2017)
Figure Illinois Injectable Anticoagulants Sales and Growth (2012-2017)
Table Illinois Injectable Anticoagulants Sales by Type (2012-2017)
Table Illinois Injectable Anticoagulants Sales Market Share by Type (2012-2017)
Table Illinois Injectable Anticoagulants Sales by Application (2012-2017)
Table Illinois Injectable Anticoagulants Sales Market Share by Application (2012-2017)
Figure United States Injectable Anticoagulants Sales, Revenue and Growth Rate (2017-2022)
Table United States Injectable Anticoagulants Sales Forecast by States (2017-2022)
Table United States Injectable Anticoagulants Market Share Forecast by States (2017-2022)
Table United States Injectable Anticoagulants Sales Forecast by Type (2017-2022)
Table United States Injectable Anticoagulants Market Share Forecast by Type (2017-2022)
Table United States Injectable Anticoagulants Sales Forecast by Application (2017-2022)
Table United States Injectable Anticoagulants Market Share Forecast by Application (2017-2022)
Table Sales Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Injectable Anticoagulants
Figure Manufacturing Process Analysis of Injectable Anticoagulants
Figure Injectable Anticoagulants Industrial Chain Analysis
Table Raw Materials Sources of Injectable Anticoagulants Major Manufacturers in 2016
Table Major Buyers of Injectable Anticoagulants
Table Distributors/Traders/ Dealers List